NASDAQ:BLPH
Bellerophon Therapeutics Stock News
$0.0625
+0.0112 (+21.83%)
At Close: May 02, 2024
The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection
12:00am, Thursday, 19'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week highs on March 18)
Biomerica, Inc. (NASDAQ...
FDA OKs new use of Boehringer Ingelheim's Ofev
07:20pm, Monday, 09'th Mar 2020
Under Priority Review and Breakthrough Therapy status, the FDA approves privately held Boehringer Ingelheim's Ofev (nintedanib) oral capsules for the treatment of patients with chronic fibrosing (scar
The Week Ahead In Biotech: Biopharma Earnings Pick Up Pace
11:38pm, Sunday, 23'rd Feb 2020
Biotech stocks turned in a lackadaisical performance last week amid earnings releases by smid-cap stocks, a few clinical readouts and data presentations at conferences and a handful of FDA verdicts. M
Biotech Stock Roundup: INCY's Solid Q4 Results, EPZM & SGEN's Pipeline Updates
02:21pm, Wednesday, 19'th Feb 2020
It was a low-key week for the biotech sector with updates from just a few small biotech companies.
The Daily Biotech Pulse: FDA Snub For Merck, Priority Review For Roche's Tecentriq sBLA
12:21pm, Wednesday, 19'th Feb 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 18) Adverum Biotechnologies Inc (NASDAQ: ADVM ) Anavex
Mid-Morning Market Update: Markets Open Lower; Apple To Miss Q2 Revenue Guidance
03:12pm, Tuesday, 18'th Feb 2020
Following the market opening Tuesday, the Dow traded down 0.34% to 29298.15 while the NASDAQ fell 0.10% to 9721.71. The S&P also fell, dropping 0.19% to 3,373.88.
Leading and...
TSLA, KR among premarket gainers
02:15pm, Tuesday, 18'th Feb 2020
Bellerophon Therapeutics (NASDAQ:BLPH) +67% on positive top-line data from a recently completed acute, intra-patient, dose escalation, hemodynamics study of INOpulse for the treatment of Pulmonary Hy
Bellerophon Therapeutics Shares Rip Higher On Phase 2 Hypertension Study Results
12:00am, Tuesday, 18'th Feb 2020
Shares of biotherapeutics company Bellerophon Therapeutics Inc (NASDAQ: BLPH) were more than doubling Tuesday following a positive clinical readout from the company....
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs Feb. 13.) Anavex Life Sciences Corp (NASDAQ: AVXL
The Daily Biotech Pulse: Deciphera Cancer Drug Gets Priority Review, Fast Track Designation For Soligenix, Revolution Medicines IPO
01:05pm, Thursday, 13'th Feb 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 12) AbbVie Inc (NYSE: ABBV ) Agile Therapeutics Inc (N
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 10) AbbVie Inc (NYSE: ABBV ) Allergan plc (NYSE: AGN )
